14 gute gruende Dara Biosciences zu kaufen
Seite 7 von 7 Neuester Beitrag: 25.04.21 00:01 | ||||
Eröffnet am: | 04.11.14 15:18 | von: eknarfguckst. | Anzahl Beiträge: | 156 |
Neuester Beitrag: | 25.04.21 00:01 | von: Antjedlvoa | Leser gesamt: | 28.601 |
Forum: | Hot-Stocks | Leser heute: | 12 | |
Bewertet mit: | ||||
Seite: < 1 | 1 | 2 | 3 | 4 | 5 | 6 | > |
http://www.propertymentorgroup.com/...uticals-inc-nasdaqaqxp/1298920/
da jemand den richtigen gefunden , der bei den DaraStinkern ermittelt
Brower Piven is the only firm headquartered in Maryland with a practice dedicated primarily to shareholder class action litigation.
http://www.businesswire.com/news/home/...-Based-Securities-Litigation
vielleicht ergibt sich da was
http://money.cnn.com/news/newsfeeds/articles/...ire/11G055062-001.htm
zwar schon älter....
DARA BioSciences Announces U.S. Launch of Oravig(R) (miconazole), the First and Only Orally-Dissolving Buccal Tablet Available for Treatment of Adults With Oral Thrush
http://www.darabio.com/media-center/press-releases?detail=652
DARA Biosciences: An Attractive Short Term Merger Play
Nov. 30, 2015 2:32 PM ET | About: DARA Biosciences, Inc. (DARA)
Disclosure: I am/we are long DARA. (More...)
Summary
•
DARA is planning to be acquired by UK-listed Midatech Pharma.
•
Midatech's offer to DARA shareholders consists of ADRs as well as a CVR based on certain milestones.
•
After the deal is completed Midatech's ADRs will start trading in the US.
•
Due to lack of institutional interest DARA trades at a 16% discount to Midatech's offer (excl. CVR).
•
DARA's shareholders will vote on this deal on Wednesday, making this an attractive short term play.